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Experimental diabetes induces functional and structural changes ing dialysis in Western Europe and United States [1].
in the peritoneum. Peritoneal dialysis (PD) is now established as an alterna-
Background. Peritoneal dialysis (PD) is an established renal tive renal replacement therapy to hemodialysis in dia-replacement therapy in diabetic patients, but the influence of
betic patients. The choice of a dialysis modality in dia-diabetes on the peritoneal membrane (PM) remains debated.
We have used functional, biochemical and molecular studies betic patients is difficult and must take into account both
in vivo and in vitro to substantiate the changes induced by dia- the lower survival rate of such patients in general [2]
betes and hyperglycemia in the PM. and the lower technique survival rate of PD [1]. Indeed,Methods. Peritoneal equilibration tests were performed 2,
progressive alterations in the peritoneal membrane (PM),4, and 6 weeks after induction of diabetes with streptozotocin
(STZ) in rats. Morphological analyses, determination of nitric in particular fibrosis and vascular proliferation, are re-
oxide synthase (NOS) activities, and expression studies for NOS sponsible for alterations of transport properties leading
isoforms and advanced glycation end products (AGE) were per- to ultrafiltration failure in up to 50% of long-term PDformed in parallel. Additional studies were conducted in dia-
patients [3]. In that context, it remains particularly im-betic rats treated with insulin, non-diabetic rats fed with urea,
and cultured bovine aortic endothelial cells (BAEC). portant to define the potential effect of diabetes on PM.
Results. In comparison with controls, diabetic rats were All forms of diabetes are characterized by microvas-
characterized by: increased permeability for small solutes and cular changes including endothelial dysfunction, increaseddecreased sodium sieving; capillary proliferation; increased en-
microvascular permeability, and vascular proliferation [4].dothelial NOS (eNOS) and AGE immunoreactivity; up-regula-
tion of eNOS and down-regulation of neuronal NOS; and in- The molecular mechanisms responsible for diabetes-asso-
creased NOS activity in the PM. The changes, which culminated ciated microvascular disease include accumulation of ad-
at week 6, were prevented by chronic insulin treatment in dia- vanced glycation end products (AGE), release of growthbetic rats. In contrast to hyperglycemia, hyperosmolality alone
factors such as the vascular endothelial growth factordid not induce functional or structural changes in the PM.
Studies in BAEC showed that high glucose incubation led to (VEGF), and modifications of the l-arginine:nitric oxide
increased activity and expression of eNOS, a prerequisite for (NO) pathway [4, 5]. Recent studies in animal models
vascular proliferation. and PD patients suggest that the PM alteration that oc-Conclusions. These data demonstrate that chronic hypergly-
curs with time on PD has similar pathophysiological fea-cemia is associated with functional and structural changes in
the peritoneum that parallel with selective regulation of NOS tures [3, 6–8]. Thus, it is tempting to hypothesize that
isoforms and AGE deposits. The alterations are prevented by microvascular alterations observed in diabetic patients
insulin treatment, which suggests that adequate control of dia- potentially affect the structure and function of the PM.betes can preserve PM integrity in diabetic patients prior to PD.
To date investigations of the effect of diabetes on PM
have yielded conflicting results. The CANUSA prospec-
tive study showed a greater proportion of diabetic pa-Diabetic nephropathy is the single most common cause
tients among PD patients characterized as high transport-of end-stage renal disease (ESRD), with diabetic patients
ers [9]. Studies of PM transport revealed that diabeticaccounting for approximately 30% of patients undergo-
patients have a higher permeability for creatinine [10, 11]
and lower transcapillary ultrafiltration [12] than non-dia-Key words: advanced glycation, diabetes, hyperglycemia, hyperosmo-
lality, insulin, nitric oxide, peritoneal dialysis. betic patients. However, these differences are no longer
observed in other series [13, 14]. The discrepancies mayReceived for publication December 28, 2001
be explained, at least in part, by individual variability inand in revised form March 14, 2002
Accepted for publication March 19, 2002 peritoneal permeability [14]. In addition, the central role
of hyperglycemia in diabetic complications suggests that 2002 by the International Society of Nephrology
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glycemic control prior to PD initiation might be a critical PD and biological parameters; tissue sampling
factor for PM alterations. Finally, the existence of diabe- Rats were anesthetized and a two-hour PD exchange
tiform changes associated with continuous exposure of with 15 mL of 3.86% glucose dialysate (Dianeal; Baxter,
the PM to high glucose concentrations in the dialysate Nivelles, Belgium) was performed as described [15]. Trans-
[3, 8] implies that potential modifications related to dia- port of low molecular weight solutes was assessed by the
betes per se must be investigated before initiating PD. dialysate-over-plasma ratio (D/P) of urea and creatinine,
The aim of this study was to use the streptozotocin and sodium sieving was defined as the decrease in dialy-
(STZ)-induced diabetic rat model to investigate the ef- sate-over-plasma ratio for sodium during the first 30 min-
fects of diabetes on the structure and function of the PM. utes of the dwell [15]. A group of six-week diabetic rats
The evaluation of permeability parameters was com- (N 3) was treated with a continuous infusion of insulin
pleted with morphological studies, determinations of NO in order to control the glycemia during the dwell only.
synthase (NOS) expression and enzymatic activity, and Six units of Actrapid (Novo Nordisk, Bagsvaerd, Den-
expression of AGE in the peritoneum. The specific con- mark) were dissolved in 10 mL 0.9% NaCl and infused
tributions of chronic hyperglycemia and hyperosmolality 40 minutes before and during the entire dwell, with an
were evaluated further in diabetic rats treated with insu- adjustment of infusion rate to maintain normoglycemia.
lin, rats fed with urea, and cultured endothelial cells. Plasma and dialysate samples were collected at 0, 30,
60, and 120 minutes of dwell time. Urea, creatinine, he-
matocrit, glucose, sodium, potassium, total protein, andMETHODS
osmolality were assayed by standard methods [15]. Fruc-Laboratory animals
tosamine and total protein levels were determined on
Studies were performed in female, 12-week-old Wistar the first plasma sample only. White blood cells (WBC)
rats (Iffa Credo, Brussels, Belgium). Diabetes was in- were counted in a Bu¨rker chamber, and dialysate cul-
duced by IV injection of streptozotocin (STZ; 65 mg/kg; tures were obtained [15]. Plasma levels of prealbumin
Pfanstiel, Davenham, UK) dissolved in 0.25 mL citrate and amino acids were measured in six-week rats by neph-
buffer. Two days after STZ or vehicle injection, glycemia elometry and ion-exchange chromatography [16]. At the
was verified and rats with a plasma glucose greater than
end of the dwell, animals were sacrificed by exsanguina-
14 mmol/L were defined as diabetic. At that time, slow
tion and similar samples were processed for fixation in
release (1 U/24 h) insulin implants (Linshin, Scarbor-
4% paraformaldehyde (visceral and parietal peritoneum)ough, Canada) were used to maintain moderate hyper-
or protein extraction (visceral peritoneum) as previouslyglycemia [7]. Control rats received placebo implants
detailed [15, 16].composed of palmitic acid (Linshin). Experiments were
carried out at week 2 (N  9), 4 (N  10), and 6 (N  Antibodies
13) after injection of STZ (diabetic rats) or vehicle (con-
The NOS isoforms were detected with well-charac-trols). Another group of diabetic rats (N  7) was main-
terized monoclonal antibodies (Transduction Labora-tained euglycemic during six weeks by implanting insulin
tories, Lexington, KY, USA) [17]. Additional antibodiespellets as required by daily determination of blood glu-
included affinity-purified rabbit antibodies against car-cose levels obtained by tail tipping. A parallel group of
boxymethyl lysine (CML) and pentosidine [16], and aqua-sham rats (N  5) underwent daily tail tipping and im-
porin-1 (AQP1; Chemicon, Temecula, CA, USA); poly-plantation of placebo pellets at the same frequency as
clonal rabbit antibodies against S-nitrosocysteine (Alexis,the diabetic rats. Control, sham and diabetic rats had ac-
Lausen, Switzerland) [18]; monoclonal antibodies againstcess to standard chow and tap water ad libitum. In order
CML [16] and -actin (Sigma Chemical Co., St. Louis,to control for the high plasma osmolality in diabetic rats,
MO, USA). Positive immunoblot controls included ly-we tested chronic, oral administration of mannitol or
sates from bovine aortic endothelial cells (endothe-glycerol in rats. These osmotic agents were not tolerated
lial NOS, eNOS), mouse macrophages (inducible NOS,and did not yield consistent hyperosmolality over six
iNOS), and rat pituitary gland (neuronal NOS, nNOS)weeks. Thus, two additional groups of non-diabetic rats
(Santa Cruz Biotechnology, Santa Cruz, CA, USA).received drinking water supplemented (N  6) or not
(N 4) with urea (600 mOsm/kg) for the six week study
Western blot analysesperiod. Plasma osmolality and urea levels were measured
Sodium dodecyl sulfate-polyacrylamide gel electro-weekly and urea intake was adjusted to match the osmo-
phoresis (SDS-PAGE) and immunoblotting were per-lality levels of diabetic rats. Peritoneal transport studies
formed on visceral peritoneum samples as describedfollowed by tissue sampling were performed systemati-
[15–17]. Efficiency of transfer to nitrocellulose was testedcally in all experimental groups. The experiments were
by Ponceau red (Sigma) staining and -actin immunore-conducted in agreement with local prescriptions and the
NIH Guide for the Care and Use of animals. activity. After blocking, membranes were incubated with
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the primary antibody at 4C overnight. The membranes NOS activity. Determinations were performed in dupli-
cate on samples randomly selected in each group.were washed, incubated for one hour at room tempera-
ture with the appropriate peroxidase-labeled secondary
Cell culturesantibodies (Dako), and visualized with chemilumines-
Bovine aortic endothelial cells (BAEC; Cell Systems,cence (Amersham, Little Chalfont, UK). Densitometry
Kirkland, WA, USA) were cultured as described [19].analyses were performed with a studioStar Scanner (Agfa-
Cells were first grown to confluence and then culturedGevaert, Mortsel, Belgium) using the NIH-Image V1-57
in 5.5 mmol/L d-glucose (control), high glucose concen-software. The relative optical densities (in %, relative
trations (16 or 22 mmol/L d-glucose) or high osmolalityto the age-matched controls) were obtained in duplicate.
(d-mannitol 10.5 mmol/L and 16.5 mmol/L; l-glucose
Immunohistochemistry 16.5 mmol/L) for six days with concomitant lowering of
the serum concentration in the medium to 2%, in orderImmunostaining was performed on 6-m sections
to keep the cells in the quiescent state. Cells for thefrom visceral and parietal peritoneum samples embed-
experiments were used between passages 2 and 5.ded in paraffin [15, 17]. After blocking in 0.3% H2O2
and incubation with 10% normal serum, sections were
NOx measurements
incubated successively for 45 minutes each with the pri-
Quantitative analysis of nitrate and nitrite (NOx) wasmary antibody, biotinylated IgG (Vector Laboratories,
used as an index of NO production in the BAEC systemBurlingame, CA, USA), and avidin-biotin peroxidase
[19]. Briefly, aliquots of the medium bathing intact cells(Vector). Immunolabeling was visualized using amino-
were collected and processed through a cadmium-basedethylcarbazole (Vector). The specificity of the immuno-
microreductor chamber (WPI, Aston, UK) to quantita-labeling was confirmed by incubation with non-immune
tively reduce nitrate to nitrite. Acidic iodide was thenrabbit or mouse IgG (Dako, Hamburg, Germany); or
used to convert nitrite to NO that was electrochemicallyafter incubation with 0.2% HgCl2 as appropriate for
measured with a NO-selective microsensor (WPI). AllS-nitrosocysteine [18]. Immunostaining for eNOS was
experiments were carried out in the presence of 7.5 U/mLquantified by image analysis [16]. Random fields (a mean
superoxide dismutase. Adequate controls using eitherof 7 per slide) were selected in at least five different
vehicle or NOS inhibitors were routinely performed inslides in each group, digitized through a Leitz Ortholux
parallel. Data were normalized for the amount of proteinmicroscope (Wetzlar, Germany) coupled with a JVC
in the dish or in the lysate.KY-F58 color digital camera (JVC, Tokyo, Japan), and
analyzed by a KS-400 system (Zeiss, Munich, Germany) Data analysis
in order to quantify the density of stained capillaries Data are presented as mean  SEM. Comparisons
(N/field). A capillary was defined as a single endothelial between results from different groups were performed
cell lining the vessel. The slides were coded and analyzed using the Student t test or one-way ANOVA, as appro-
on a single-blind basis by the same operator. priate. Statistical significance was defined as P  0.05.
NOS activity assay
RESULTSNitric oxide synthase enzymatic activities in the vis-
ceral peritoneum were measured using the l-citrulline Clinical and biological parameters
assay as described [17]. Briefly, 350 g of tissue extract Diabetic rats followed at two, four, and six weeks had
containing 20 mmol/L CHAPS were added to 200 L higher plasma glucose, osmolality and fructosamine lev-
of Tris buffer (50 mmol/L, pH 7.4) containing 10 mmol/L els, and significantly lower body weights than age-matched
dithiothreitol (DTT), 10 g/mL calmodulin, 1 mmol/L controls (Table 1, series A). Plasma creatinine levels were
nicotinamide adenine dinucleotide phosphate (NADPH), lower in diabetic rats, in relation with glomerular hyper-
4mol/L flavin adenosine dinucleotide (FAD), 4mol/L filtration associated with early diabetes and lower body
flavin mononucleotide (FMN), 2 mol/L l-arginine, and weight [20]. Systolic blood pressure, prealbumin and urea
103 mCi/mL l-[3H]-arginine (NEN Life Science, Zaven- levels, and hematocrit values were similar in diabetic rats
tem, Belgium). Assays were performed for 30 minutes at (treated or not with insulin) and age-matched controls.
37C. l-[3H]-citrulline was separated by cation-exchange Chronic insulin treatment for six weeks in diabetic rats
chromatography (Bio-Rad) and quantified by liquid scin- was effective in maintaining euglycemia as shown by
tillation. The NOS activity (pmol citrulline/mg protein/ plasma glucose and fructosamine levels, and normaliza-
min) was determined by subtracting counts obtained with tion of body weight (Table 1, series B). Plasma citrulline
or without 1 mmol/L L-NMMA. Assays were performed levels were significantly higher in six-week diabetic rats
with or without Ca2 to measure total versus Ca2-inde- than in controls (127  10 vs. 88  5 mol/L) and six-
week diabetic rats treated with insulin (93  3 mol/L).pendent NOS activities, and calculate Ca2-dependent
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Table 1. Clinical and biological parameters of the three series of rats
Plasma Plasma
Body Plasma Plasma Plasma urea creatinine
Time weight glucose osmolality fructosamine
Series Group week N g mmol/L mOsm/kg lmol/g protein mg/dL
A Control 2 5 2785 9.50.7 2992 2.50.1 311 0.340.02
Control 4 5 2766 8.30.3 2962 1.60.4 364 0.250.02
Control 6 6 2945 8.70.4 2962 2.20.1 374 0.370.02
Diabetic 2 4 242 11a 23.73.1a 3068 40.7a 426 0.210.01b
Diabetic 4 5 2594a 24.91.2b 3062b 5.20.4b 344 0.260.02
Diabetic 6 7 2439b 25.41.8b 3147b 5.20.2b 467 0.190.01b
B Sham 6 5 2794 7.80.3 2961 2.20.1 291 0.290.02
Diabetic 
chronic insulin 6 7 2844 8.20.3 2971 2.30.1 341 0.310.02
C Control 6 4 2773 8.30.5 2941 1.70.5 342 0.380.04
Urea 6 6 2728 9.60.3 3156 1.60.3 11122b 0.300.03
a P  0.05, b P  0.01 vs. age-matched control
A similar trend was observed for plasma arginine levels (1.2  0.2 mg/L) and diabetic rats treated with insulin
(1.4  0.1 mg/L).(124  25 vs. 92  14 mol/L, six-week diabetics vs.
Immunostaining for eNOS was performed in six-weekcontrols, NS). The clinical and biological parameters of
diabetic and control rats (Fig. 2 A-D). As previouslythe six-week diabetic rats that were treated acutely with
described [15, 21], a faint signal for eNOS was locatedinsulin during the dwell were similar (plasma glucose
in the endothelium lining peritoneal blood vessels of24.8 0.1 mmol/L; plasma osmolality 310 3 mOsm/kg;
control rats (Fig. 2A). The signal intensity and the den-plasma fructosamine 4.5  0.2 mol/g protein; N  3)
sity of capillaries for eNOS were increased in six-weekto other six-week diabetic rats. Absence of peritonitis
diabetic rats (Fig. 2B). These changes were preventedwas demonstrated by a clear dialysate at the end of the
with chronic insulin treatment (Fig. 2C). Staining fordwell, low dialysate WBC counts, and negative dialysate
AQP1 also identified vascular proliferation in the perito-cultures.
neum of diabetic rats (data not shown). Morphometric
analysis in random sections of the visceral peritoneumEffects of experimental diabetes on permeability and
confirmed the higher density of capillaries stained forstructure of the PM
eNOS in diabetic rats versus controls (8.1 0.9 vs. 2.7Functional parameters evaluated at six weeks showed
0.5 capillaries/field, P  0.001). In diabetic rats treatedthat diabetes was associated with a significant increase
with insulin for six weeks, the density of positive capillar-in peritoneal permeability for small solutes such as urea
ies was similar to that observed in controls and shamand creatinine (Fig. 1A). Longitudinal studies showed
rats (2.5  0.5 vs. 1.8  1.4 capillaries/field; Fig. 3).that the permeability progressively increased from two
To substantiate the link between diabetes, hyperglyce-to six weeks of diabetes (Fig. 1B). The increased perme-
mia and AGE deposition, we performed immunostainingability in six-week diabetic rats was not modified by acute
for CML and pentosidine in representative sections of
normalization of glycemia with insulin during the dwell.
the peritoneum (Fig. 2 E-H). A weak staining for CML
In contrast, peritoneal permeability of diabetic rats was detected in control rats. The staining intensity was
treated with insulin for six weeks was similar to that of significantly increased in six-week diabetic rats, mainly
controls (Fig. 1B). Similar observations were made for located in capillary and vascular walls. As previously ob-
creatinine permeability (data not shown). Despite the served [16], the staining was consistently more intense for
maintenance of a significant osmotic gradient (similar CML than pentosidine, but both AGE accumulated on the
D/D0 glucose during the dwell), sodium sieving was sig- same structures. Additional modifications observed in six-
nificantly lower in the six-week diabetic rats than in con- week diabetic rats included a major increase in the immu-
trols. The difference was abolished when diabetic rats noreactivity for S-nitrosocysteine, particularly located in
were treated with insulin for six weeks (Fig. 1C). Net the mesothelial and endothelial cell layers (Fig. 2 I-J).
ultrafiltration (volume out  volume in) was similar in It must be noted that these structural changes were also
all groups of rats, although a slight, not significant de- observed in the parietal peritoneum of diabetic rats.
crease was observed in six-week diabetic rats (8.3  0.8
Effects of experimental diabetes on expression andmL) versus controls (8.9  0.3 mL) and diabetic rats
activity of NOS in the peritoneumtreated with insulin (9.3  0.2 mL). Similarly, there was
a trend for higher albumin levels in the dialysate in Longitudinal determinations of NOS activity in the
visceral peritoneum showed that, in comparison withsix-week diabetic rats (1.5  0.1 mg/L) versus controls
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Fig. 1. Peritoneal permeability parameters in control and diabetic rats. (A) Dialysate-to-plasma (D/P) ratios of urea and creatinine in six-week
control () and streptozotocin (STZ)-induced diabetic rats () during a two-hour exchange with 15 mL of 3.86% glucose. A significant increase
in peritoneal permeability for urea and creatinine is observed in diabetic rats. (B) Time-course of increase in peritoneal permeability for urea
(expressed as the area under the curve for the D/P urea during the 2-hour dwell) in diabetic rats () as compared to their controls (). Correction
of hyperglycemia with insulin acutely during the dwell ( ) does not modify urea permeability in six-week diabetic rats. In contrast, chronic insulin
treatment of diabetic rats for six weeks ( ) completely prevents the permeability modifications. *P  0.05 vs. age-matched control; †P  0.05 vs.
six-week diabetic  chronic insulin. (C ) Dialysate-to-plasma (D/P) ratio of sodium in control () and six-week diabetic () rats during the 2-hour
dwell. A significant loss of sodium sieving (that is, a reduced decrease in D/P sodium at 30 min) is observed in diabetic rats, despite maintenance
of the osmotic gradient. (D) The same parameters in non-diabetic sham () and diabetic rats treated for six weeks with insulin (). Treatment
of diabetic rats with insulin reverses the loss of sodium sieving. The functional parameters were obtained for all rats in each experimental series.
age-matched controls, diabetic rats had a significant, ap- Effects of chronic hyperosmolality
proximately 50% increase in total NOS activity at four In order to distinguish between the contribution of
and six weeks (Fig. 4). The increase in total NOS activity hyperglycemia versus hyperosmolality, urea was admin-
was solely due to Ca2-dependent NOS. In contrast, NOS istered for six weeks to another series of rats. Urea intake
activity in the peritoneum was similar to control levels was adjusted weekly, and plasma osmolality levels were
in diabetic rats treated with insulin for six weeks (Fig. 4). similar to those observed in two, four and six week dia-
Immunoblot analyses demonstrated that the increased betic rats (Fig. 6A). Despite high osmolality levels (Ta-
Ca2-dependent NOS activity detected in the diabetic ble 1, series C), the peritoneal permeability for urea and
peritoneum was due to the up-regulation of eNOS creatinine was similar in six-week urea-treated rats and
(140 kD; Fig. 5A). It is interesting that the six-week controls (Fig. 6B). Both NOS enzymatic activities (Fig. 6C)
diabetic rats also showed a significant decrease in nNOS and expression levels of eNOS and nNOS in the perito-
(155 kD) expression (Fig. 5B). Densitometry analysis neum (Fig. 6D) were similar in urea-treated rats versus
(Fig. 5D) confirmed a significant up-regulation of eNOS controls.
in diabetic rats at four weeks (50  17%, P  0.05)
Effects of high glucose versus hyperosmolality inand six weeks (116  52%, P  0.05). In contrast,
cultured endothelial cellsnNOS expression was significantly lower at six weeks
(62  10%, P  0.01). Treatment of diabetic rats with The differential effect of hyperglycemia versus hyper-
insulin for six weeks prevented the increase in eNOS osmolality on the regulation of eNOS was further inves-
expression, but only partially reverted the decrease in tigated on the well-established BAEC system [19]. As
compared to a medium containing physiological levelsnNOS (Fig. 5 C-D).
Fig. 2. Structural changes in the peritoneum induced by experimental diabetes. (A-D) Immunostaining for endothelial nitric oxide synthase
(eNOS) in the visceral peritoneum of 6-week control (A) and diabetic (B-D) rats. (A) The eNOS is located in the endothelium lining peritoneal
capillaries. (B) The signal intensity, as well as the density of stained capillaries are increased in 6-week diabetic rats. (C) A representative staining
for eNOS in the visceral peritoneum of 6-week diabetic rats treated with insulin shows a staining pattern similar to controls (compare with A).
(D) No specific staining is detected when peritoneum sections of 6-week diabetic rats are incubated without primary antibody (bar in A-D, 50
m). (E-H ) Immunoreactivity for carboxymethyl lysine (CML) in the visceral peritoneum of 6-week control (E, F) and diabetic (G, H) rats. A
major increase in CML staining is observed in 6-week diabetic rats, particularly concentrated in the walls of peritoneal capillaries and small arteries
(bar in E-H, 75 m). (I-J ) Immunostaining for S-nitrosocysteine in the visceral peritoneum of 6-week control (I) and diabetic (J) rats. Diabetes
induces a major increase in S-nitrosocysteine immunoreactivity in the peritoneal membrane (bar in I-J, 50 m).
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Fig. 4. Nitric oxide synthase (NOS) enzymatic activity in the perito-Fig. 3. Density of capillaries stained for eNOS in the peritoneum. Com-
neum of control and diabetic rats. Total NOS activity was assayed byputer-assisted morphometry in the visceral peritoneum shows a higher
the conversion of l-[3H]-arginine to l-[3H]-citrulline in the visceraldensity of capillaries stained for eNOS in 6-week diabetic rats (8.1 
peritoneum. Assays were performed with or without Ca2, to distinguish0.9 capillaries/field) versus controls (2.7  0.5 capillaries/field, P 
between Ca2-dependent () and Ca2-independent () NOS activities.0.001). The density of capillaries in diabetic rats treated with insulin
In comparison with age-matched controls, total NOS activity is signifi-for six weeks (2.5  0.5 capillaries/field) is similar to controls. A mean
cantly increased at 4 weeks (0.145  0.009 vs. 0.096  0.006 pmolof 7 fields randomly selected per sample and 5 samples in each group
citrulline/mg protein per min, 52 9% increase, P 0.05) and 6 weekswere analyzed.
(0.195  0.02 vs. 0.127  0.01 pmol citrulline/mg protein per min, 54 
12% increase, P  0.05). Chronic insulin treatment in 6-week diabetic
rats prevents the increase in total and Ca2-dependent NOS activities.
NOS activities (N  4 in each group) are normalized against the values
obtained in the appropriate age-matched controls. *P  0.05 vs. age-of d-glucose (5.5 mmol/L), a significant increase in both
matched control; †P  0.05 vs. 6-week diabetic  chronic insulin.eNOS expression (Fig. 7A) and activity (Fig. 7B) was
observed in BAEC cultured in high glucose medium for
four and six days. In contrast, culture in an equivalent
hyperosmolar medium (d-mannitol) had no effect on these channel AQP1 [14, 21]. Aquaporin-1 is a robust plasma
parameters. Immunoblot analysis confirmed the increased membrane protein, and previous studies in rat and hu-
expression of eNOS in BAEC exposed to high glucose man failed to document any quantitative decrease in its
(Fig. 7C). The effect was dose-dependent and specific, expression in the PM despite a loss or even a disappear-
as shown by the absence of up-regulation when d-manni- ance of sodium sieving [15, 21, 22]. On the other hand,
tol and l-glucose were used as osmotic controls. the loss of sodium sieving in these studies is consistently
paralleled by an increase in endothelial NOS activity
[15, 21, 22] and S-nitrosylation of the PM including theDISCUSSION
capillary endothelium [18]. These two biochemical modi-
The present work shows that STZ-induced diabetes is fications also occur in the PM of diabetic rats (Figs. 2
associated with functional and structural alterations of and 4). Thus, these data support the hypothesis that NO
the PM. These changes are characterized by increased may induce post-translational modifications of critical
transport of urea and creatinine, decreased sodium siev- residues in the PM, possibly including the cysteine 189,
ing, vascular proliferation, increased NOS activity, and which is located in a critical region of the water pore
differential expression of NOS isoforms. The changes of AQP1 [23]. The functional and structural changes
are completely prevented when diabetic rats are treated induced by diabetes in rats are similar to those described
with insulin, and they are not observed when chronic hy- in chronic uremic [16] and diabetic [7, 24] rat models.
perosmolality is induced by urea. Studies in cultured Higher permeability for creatinine [10, 11], and reduced
endothelial cells demonstrate that high glucose itself in- transcapillary water transport [12] also have been de-
creases both expression and activity of eNOS, whereas scribed in diabetic patients studied at the start of PD.
other osmotic agents have no effect in this system. Vascular changes, including neoangiogenesis and sub-
Diabetic rats are characterized by a progressive in- endothelial hyalinization, represent a central process in
crease in the permeability for small solutes and a signifi- the pathophysiology of the progressive alteration of the
cant vascular proliferation in the PM. The accompanying PM [25]. Studies in animal models and patients undergo-
increase in effective peritoneal surface area probably ing PD have shown that vascular changes in the PM
explains the higher permeability for urea and creatinine are related to the cumulative exposure to high glucose
[14]. Diabetic rats also are characterized by a significant concentration in the dialysate, with eventual accumula-
loss of sodium sieving despite an effective osmotic gra- tion of AGE, release of growth factors including VEGF,
dient, which suggests a decrease in water permeability and regulation of NOS isoforms [3, 6, 8, 26]. It is impor-
tant to keep in mind that the extent and nature of vascu-across the ultrasmall pores corresponding to the water
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Fig. 5. Effects of experimental diabetes on the expression of NOS isoforms in the peritoneum. (A and B) Representative immunoblots for eNOS
(140 kD) and nNOS (155 kD) in the visceral peritoneum of control and STZ-induced diabetic rats. (C ) Representative immunoblots for eNOS
and nNOS in visceral peritoneum samples obtained from diabetic rats treated for 6 weeks with insulin and their sham, non-diabetic controls.
Samples (40 g protein/lane) were run in SDS-PAGE (7.5%), transferred to nitrocellulose and the blots were probed with monoclonal antibodies
against eNOS or nNOS. (D) Relative optical densities of eNOS and nNOS in diabetic (treated or not with insulin) versus control rats. The densitometry
values are normalized against those obtained in the appropriate, age-matched control or sham rats. As compared with controls, the signal intensity
for eNOS is significantly increased in diabetic rats at 4 weeks (50  17%, *P  0.05) and 6 weeks (116  52%, *P  0.05), whereas there is a
significant decrease in nNOS expression at 6 weeks (62  10%, *P 0.05). The increase in eNOS expression is not observed in diabetic rats treated
with insulin for 6 weeks, and the same treatment partially reverses the decrease in nNOS expression observed in diabetic rats. *P  0.05 vs. age-
matched controls; †P  0.05 vs. 6-week diabetic  chronic insulin.
lar changes in PM may vary according to species and pression. However, the imbalance between the increase
in NOS activity (50%) and vascular density (threefold)location in the visceral or parietal peritoneum. However,
our results suggest that a series of mediators involved suggests that the NOS activity per endothelial area unit
may actually be lower in diabetic rats. Such a situation isin PD-related changes also are activated by high glucose
exposure on the vascular, endothelial side of the PM. known to induce a compensatory increase in endogenous
arginine synthesis [27], which would explain the higherIndeed, our demonstration that all the alterations of the
PM observed in diabetic rats are prevented by chronic plasma levels of l-arginine and l-citrulline detected in
the diabetic rats. In contrast to eNOS, the expression ofinsulin treatment points to hyperglycemia as a causative
agent. These findings may explain the discrepancies ob- nNOS in the PM is decreased in diabetic rats, which con-
stitutes another example of the selective degenerationserved in diabetic patients [10–14], in which variability in
intrinsic peritoneal permeability may actually reflect the of non-cholinergic, non-adrenergic, NO-releasing nerves
in diabetes [28].control of diabetes prior to the onset of PD. Thus, exactly
like in other microvascular complications of diabetes, In addition to vascular proliferation, diabetic rats are
characterized by increased levels of AGE (CML and tothe glycemic control seems to exert a key influence in the
development of vascular proliferation in the peritoneum. a lesser extent, pentosidine) in the peritoneum. Diabetes
is associated with high levels of circulating AGE, andThe PM of diabetic rats is characterized by a parallel
increase in Ca2-dependent NOS activity and eNOS ex- the latter play a central role in the initiation and accelera-
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Fig. 6. Effects of chronic hyperosmolality on peritoneal permeability and NOS expression and activities in rats fed with urea for 6 weeks. (A)
Urea-treated rats () had a significant increase in plasma osmolality as compared to controls (). Plasma osmolality was similar to STZ-induced
diabetic rats () at 2 weeks (308  2 vs. 306  8 mOsm/kg, respectively), 4 weeks (307  1 vs. 306  2 mOsm/kg, respectively) and 6 weeks
(311  3 vs. 314  7 mOsm/kg, respectively). There were 4 controls and 6 urea-treated rats. (B) Peritoneal permeability for urea and creatinine
(expressed as the area under the curve for the D/P for urea and creatinine during the 2 h-exchange) remains unchanged in urea-treated rats (N 
6, ) as compared with their controls (N  4, ). (C ) NOS activity in the visceral peritoneum of urea-treated rats and their controls: both total
NOS (; 0.156  0.02 vs. 0.140  0.02 pmol citrulline/mg protein per min, respectively) and Ca2-dependent NOS (; 0.145  0.03 vs. 0.127 
0.01 pmol citrulline/mg protein per min, respectively) activities are similar (N  4 in each group). (D) Representative immunoblots (top panel)
for eNOS (140 kD) and nNOS (155 kD) and corresponding optical densities (bottom panel) obtained in visceral peritoneum samples from urea-
treated () and control () rats. Samples (40 g protein/lane) were run in SDS-PAGE (7.5%), transferred to nitrocellulose and the blots were
probed with monoclonal antibodies against eNOS or nNOS. The signal intensity for eNOS and nNOS is similar in both groups.
tion of macro- and microvascular complications of diabe- els than diabetic rats, chronic administration of urea did
not induce functional or structural changes in the PM.tes [29]. Accumulation of AGE, linked to reactive car-
It could be argued that urea is not an effective osmole.bonyl compounds, is also thought to play a pivotal role
Thus, we investigated the effect of additional osmoticin the alteration of the PM during PD [8]. One mecha-
agents on a well-established cultured endothelial cells sys-nism of toxicity may involve liberation of VEGF and sub-
tem [19]. Exposure of BAEC to high glucose increasedsequent stimulation of endothelial cells within the PM
eNOS expression and activity, whereas these parameters[6, 30]. Preliminary data indeed show that the induction
were not influenced by osmotic agents such as l-glucose
of diabetes by STZ is followed by an early peak of VEGF or d-mannitol. These results indicate that hyperosmolality
in the PM (M.S. Stoenoiu and A.S. De Vriese, unpub- per se does not induce significant changes in the perme-
lished observations). ability and structure of the PM and does not alter eNOS
Hyperosmolality potentially activates many signaling at the protein level. Thus, high glucose alone is sufficient
pathways, and additional studies were performed to dis- to activate endothelial cells and promote the expression
tinguish between hyperglycemia and hyperosmolality- and activity of eNOS, a prerequisite for vascular prolifer-
ation [31].mediated effects. Despite similar plasma osmolality lev-
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Fig. 7. Effects of high glucose versus hyperosmolality on NOS expression and activity in cultured bovine aortic endothelial cells (BAEC). (A)
Representative immunoblot for eNOS in BAEC that have been incubated for 6 days in control conditions (d-glucose 5.5 mmol/L) vs. high glucose
alone (d-glucose 22 mmol/L) or high osmolality (d-glucose 5.5 mmol/L  d-mannitol 16.5 mmol/L). Samples (40 g protein/lane) were run in
SDS-PAGE (7.5%), transferred to nitrocellulose and the blots were probed with a monoclonal antibody against eNOS (140 kD). In comparison
with control conditions, there is a marked increase in eNOS expression when BAEC are incubated for 4 and 6 days with d-glucose 22 mmol/L.
In contrast, incubation of the BAEC with the same osmolality obtained with mannitol (d-glucose 5.5 mmol/L  d-mannitol 16.5 mmol/L) has no
effect on eNOS expression. (B) Measurement of nitrate/nitrite (NOx) release in the medium from A23187-stimulated BAEC. In comparison with
control conditions (; d-glucose 5.5 mmol/L), NOx release is increased in BAEC treated with d-glucose 22 mmol/L () for 4 and 6 days (by 60%
and 113%, respectively, *P  0.05 vs. control, N  3) but remains unchanged in cells treated with d-mannitol ( ; d-glucose 5.5 mmol/L 
d-mannitol 16.5 mmol/L). (C ) Representative immunoblot (top panel) and corresponding optical densities (bottom panel) for eNOS in BAEC
that have been incubated for 6 days in control conditions (d-glucose 5.5 mmol/L) versus high d-glucose (16 or 22 mmol/L) or corresponding high
osmolality (d-glucose 5.5 mmol/L  d-mannitol 10.5 mmol/L or 16.5 mmol/L; or d-glucose 5.5 mmol/L  l-glucose 16.5 mmol/L). The expression
of eNOS increases in a dose-dependent manner in BAEC treated with high d-glucose (16 and 22 mmol/L), whereas a similar osmolality obtained
by adding d-mannitol or l-glucose to the medium has no effect.
Although endothelial dysfunction is clearly implicated In summary, uncontrolled diabetes and hyperglycemia
are able to induce significant alterations in the PM in thisin microvascular diabetic complications [4, 5], contrast-
rat model. The alterations are prevented by chronic insu-ing results in terms of eNOS expression are obtained in
lin treatment, which points at hyperglycemia as a caus-vivo and in vitro. There is evidence that endothelium-
ative agent. These data suggest that adequate control ofdependent vasodilation is abnormal in diabetic rats [32]
diabetes prior to PD initiation can preserve the func-and diabetic patients [33], suggesting that NOS activity
tional and structural integrity of the PM.may be chronically impaired. However, an increased ex-
pression of eNOS has been documented in the vessels
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